ULS Stock Analysis: UL Solutions | NYSE
Specialty Business Services | NYSE, USA | Market Cap: 15.152m USD | 12M Return: 20.3% | US9037311076 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 60.6M
Qual. Beats: 0
Rev. Trend: 99.9%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 2.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
UL Solutions Inc. (NYSE: ULS) is a global provider of testing, inspection, and certification (TIC) services, along with related software and advisory offerings. The company is headquartered in Northbrook, Illinois, traces its origins to 1894, and completed its IPO in April 2024. It operates as a subsidiary of ULSE Inc.
The business is organized into three segments: Industrial (energy, industrial automation, engineered materials, and built environment end markets), Consumer (safety certification, global market access, and testing for electronics, medical devices, appliances, lighting, and emerging applications such as new mobility and 5G), and Software and Advisory (regulatory, supply chain, and sustainability software, including the ULTRUS platform).
UL Solutions competes in the TIC sector, which tends to grow alongside increases in product safety regulation, supply chain complexity, and sustainability disclosure requirements. Major industry peers include SGS, Bureau Veritas, Intertek, and Eurofins. ULs long-running brand recognition in product safety certification is a notable differentiator in the consumer and industrial segments.
- Energy transition testing demand fuels Industrial segment revenue growth
- ULTRUS software platform drives Software and Advisory margin expansion
- Consumer electronics cycle pressures certification volume in Consumer segment
| Net Income: 504.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 1.52 > 1.0 |
| NWC/Revenue: 11.70% < 20% (prev 8.27%; Δ 3.43% < -1%) |
| CFO/TA 0.22 > 3% & CFO 678.0m > Net Income 504.0m |
| Net Debt (292.0m) to EBITDA (978.4m): 0.30 < 3 |
| Current Ratio: 1.42 > 1.5 & < 3 |
| Outstanding Shares: last quarter (204.0m) vs 12m ago 0.49% < -2% |
| Gross Margin: 50.15% > 18% (prev 48.32%; Δ 1.83% > 0.5%) |
| Asset Turnover: 104.2% > 50% (prev 101.0%; Δ 3.16% > 0%) |
| Interest Coverage Ratio: 23.15 > 6 (EBIT TTM 740.7m / Interest Expense TTM 32.0m) |
| A: 0.12 (Total Current Assets 1.23b - Total Current Liabilities 866.0m) / Total Assets 3.12b |
| B: 0.24 (Retained Earnings 750.0m / Total Assets 3.12b) |
| C: 0.25 (EBIT TTM 740.7m / Avg Total Assets 3.02b) |
| D: 1.06 (Book Value of Equity 1.59b / Total Liabilities 1.50b) |
| Altman-Z'' = 4.32 = AA |
| DSRI: 1.03 (Receivables 710.0m/648.0m, Revenue 3.15b/2.95b) |
| GMI: 0.96 (GM 48.32% / 50.15%) |
| AQI: 0.83 (AQ_t 0.31 / AQ_t-1 0.37) |
| SGI: 1.07 (Revenue 3.15b / 2.95b) |
| TATA: -0.06 (NI 504.0m - CFO 678.0m) / TA 3.12b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of August 28, 2026, the stock is trading at USD 75.55 with a total of 434,638 shares traded. Over the past week, the price has changed by +0.39%, over one month by -16.11%, over three months by -24.79% and over the past year by +20.34%.
Current recommended Stop Loss: 72.60 (which is 3.9% or 1.2 ATR below the current price).
UL Solutions has received a consensus analysts rating of 3.82. Therefore, it is recommended to buy ULS.
- StrongBuy: 4
- Buy: 2
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 97.3 | 28.8% |
P/E Trailing = 29.9004
P/E Forward = 31.348
P/S = 4.8084
P/B = 9.3658
P/EG = 1.6766
Revenue TTM = 3.15b USD
EBIT TTM = 740.7m USD
EBITDA TTM = 978.4m USD
Long Term Debt = 301.0m USD (from longTermDebt, last quarter)
Short Term Debt = 114.0m USD (from shortTermDebt, last quarter)
Debt = 726.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 175.0m
Net Debt = 292.0m USD (calculated: Debt 726.0m - CCE 434.0m)
Enterprise Value = 15.4b USD (15.2b + Debt 726.0m - CCE 434.0m)
Interest Coverage Ratio = 23.15 (Ebit TTM 740.7m / Interest Expense TTM 32.0m)
EV/FCF = 35.42x (Enterprise Value 15.4b / FCF TTM 436.0m)
FCF Yield = 2.82% (FCF TTM 436.0m / Enterprise Value 15.4b)
FCF Margin = 13.86% (FCF TTM 436.0m / Revenue TTM 3.15b)
Net Margin = 16.02% (Net Income TTM 504.0m / Revenue TTM 3.15b)
Gross Margin = 50.15% ((Revenue TTM 3.15b - Cost of Revenue TTM 1.57b) / Revenue TTM)
Gross Margin QoQ = 51.10% (prev 50.26%)
Tobins Q-Ratio = 4.95 (Enterprise Value 15.4b / Total Assets 3.12b)
Interest Expense / Debt = 4.41% (Interest Expense 32.0m / Debt 726.0m)
Taxrate = 25.60% (181.7m / 709.7m)
NOPAT = 551.1m (EBIT 740.7m * (1 - 25.60%))
Current Ratio = 1.42 (Total Current Assets 1.23b / Total Current Liabilities 866.0m)
Debt / Equity = 0.46 (Debt 726.0m / totalStockholderEquity, last quarter 1.59b)
Debt / EBITDA = 0.30 (Net Debt 292.0m / EBITDA 978.4m)
Debt / FCF = 0.67 (Net Debt 292.0m / FCF TTM 436.0m)
Total Stockholder Equity = 1.34b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.69% (Net Income 504.0m / Total Assets 3.12b)
RoE = 37.55% (Net Income TTM 504.0m / Total Stockholder Equity 1.34b)
RoCE = 45.08% (EBIT 740.7m / Capital Employed (Equity 1.34b + L.T.Debt 301.0m))
RoIC = 24.94% (NOPAT 551.1m / Invested Capital 2.21b)
WACC = 7.22% (E(15.2b)/V(15.9b) * Re(7.41%) + D(726.0m)/V(15.9b) * Rd(4.41%) * (1-Tc(0.26)))
Discount Rate = 7.41% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 93.79 | Cagr: 0.88%
[DCF] Terminal Value 77.97% ; FCFF base≈407.2m ; Y1≈466.8m ; Y5≈687.0m
[DCF] Fair Price = 128.6 (EV 10.3b - Net Debt 292.0m = Equity 10.0b / Shares 78.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.82 | # QB: 0
Revenue Correlation: 99.94 | Revenue CAGR: 6.83% | SUE: 0.16 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.61 | Chg30d=-1.52% | Revisions=-22% | Analysts=9
EPS current Year (2026-12-31): EPS=2.32 | Chg30d=+0.60% | Revisions=+25% | GrowthEPS=+16.5% | GrowthRev=+5.2%
EPS next Year (2027-12-31): EPS=2.60 | Chg30d=+0.94% | Revisions=+21% | GrowthEPS=+12.2% | GrowthRev=+7.2%
[Analyst] Revisions Ratio: +14% (up=15, down=11)